openPR Logo
Press release

Oral Proteins and Peptides Market Report involving Key Players:Merck & Co., Inc., Novartis AG, Glaxosmithkline PLC,Astrazeneca PLC,Aegis Therapeutics LLC.

03-16-2020 07:32 PM CET | Health & Medicine

Press release from: Western Market Research

Oral Proteins and Peptides Market Report involving Key

The peptide and protein therapeutics are an important class of medicines, which are administered through the oral route to treat different diseases, which include gastric, hormonal, and metabolic disorders. These drugs hold significant potential to improve the human health. The global oral proteins and peptides market was valued at $643 million in 2016, and is estimated to reach at $8,233 million by 2028, registering a CAGR of 11.7% from 2022 to 2028.

Ask for a free Sample- https://westernmarketresearch.com/market-report/2093/-Oral-Proteins-and-Peptides-Market-by-Drug-Type-(L#sample

Upsurge in collaboration between pharmaceutical companies for drug development and surge in prevalence of chronic diseases are the key factors that augment the growth of the global oral proteins and peptides market. Moreover, rise in geriatric population and improvement in healthcare infrastructure are expected to boost the market growth.

However, low bioavailability of oral proteins and peptides and high cost associated with drug development are some of the factors that restrain the market growth. Conversely, increase in purchasing power of developing countries and rise in R&D activities by pharmaceutical companies are expected to provide new opportunities for market players in the near future.

The oral proteins and peptides market is segmented into drug type, application, and region. By drug type, the market is divided into linaclotide, plecanatide, calcitonin, insulin, and octreotide. By application, it is categorized into gastric & digestive disorders, bone diseases, diabetes, and hormonal disorders. Based on region, it is analyzed across the U.S. and rest of the world.

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis of the current market trends and future estimations from 2016 to 2028 to identify the prevailing opportunities.
The oral proteins and peptides market size and estimations are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on region assists to understand the regional market and the strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Click and ask for instant 30% discount @ WMR - https://westernmarketresearch.com/market-report/2093/-Oral-Proteins-and-Peptides-Market-by-Drug-Type-(L#inquiry

KEY MARKET SEGMENTS

By Drug Type

Linaclotide
Plecanatide
Calcitonin
Insulin
Octreotide

By Application

Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders

Buy this Report Now - https://westernmarketresearch.com/buynow.php?id=2093

By Region

U.S.
Rest of the world

The list of key players operating in this market includes:

Allergan plc
AstraZeneca plc
Biocon Limited
Chiasma, Inc.
Proxima Concepts Limited (Diabetology Ltd.)
Generex Biotechnology Corp.
Novo Nordisk A/S
Synergy Pharmaceuticals Inc.
Tarsa Therapeutics Inc.

Read in Details click on below - https://westernmarketresearch.com/market-report/2093/-Oral-Proteins-and-Peptides-Market-by-Drug-Type-(L

For More info.
Contact.

Kevin Allen (Marketing & Sales)
https://www.linkedin.com/company/western-market-research/?originalSubdomain=in
WESTERN MARKET RESEARCH
Office No.6, CN7, Survey No. 94-95
Pune, Maharashtra, India.
Email- info@westmarketreport.com
Phone No (US)+1 (650) 741-1345
Phone No (IN) +91 7757044254
https://westernmarketresearch.com/

NEAR INDIRA SHANKAR NAGARI, BHUSARI COLONY,KOTHRUD

Western Market Research is a global player, among top market research companies, with niche in intelligent industry analysis, business report, syndicate, comprehensive and secondary research report having in-depth data analysis based on history trends and forecast, segmentation, major players, market size and market share. Our research firm comprises of analysts with insights on market overview providing business consulting services resulting in breakthrough primary and secondary market research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oral Proteins and Peptides Market Report involving Key Players:Merck & Co., Inc., Novartis AG, Glaxosmithkline PLC,Astrazeneca PLC,Aegis Therapeutics LLC. here

News-ID: 1969623 • Views:

More Releases from Western Market Research

Reverse Osmosis (RO) Membrane Market- Top Key Players- Axeon Water Technologies, Dow Water & Process Solutions, General Electric, GE Water & Process Technologies
Reverse Osmosis (RO) Membrane Market- Top Key Players- Axeon Water Technologies, …
Reverse Osmosis (RO) Membrane Market Report is expected to grow at CAGR 12.5% by 2028. Reverse Osmosis (RO) Membrane Market Report was $XX Million in 2020 and is expected to reach $XX Billion by the forecasted period 2021 to 2028. Reverse osmosis is a technology used to remove most contaminants from water by pushing water under pressure through a semi-permeable membrane. Reverse osmosis (RO) membranes play a key role in
Global Metaverse Market is expected to register a CAGR at 45.8% by 2028 ,Top Key Players- Facebook Inc, AR Solution Cop, Nvidia Corporation, Nextech AR Solutions Corp, Unity Technologies Inc, Lilith Games, Roblox Corporation, Tencent Holdings Ltd, ByteDan
Global Metaverse Market is expected to register a CAGR at 45.8% by 2028 ,Top Key …
The Metaverse Market is expected to register a CAGR at 45.8% by 2028 Metaverse Market Report was $XX Million in 2020 and is expected to reach $XX Billion by the forecasted period 2021 to 2028. The metaverse can be defined as a simulated digital surroundings that makes use of augmented reality (AR), virtual truth (VR), and block chain, in conjunction with concepts from social media, to create areas for wealthy user interplay
Nuclear Medicine radiopharmaceuticals Stable Isotopes Market, Top Key Players- Bayer AG, GE Company, Cardinal Health, Jubilant Life science, Lantheus Medical Imaging, Siemens AG
Nuclear Medicine radiopharmaceuticals Stable Isotopes Market, Top Key Players- B …
Nuclear Medicine radiopharmaceuticals Stable Isotopes Market Report is expected to grow at CAGR XX% by 2028. Nuclear Medicine radiopharmaceuticals Stable Isotopes Market Report was $XX Million in 2020 and is expected to reach $XX Billion by the forecasted period 2021 to 2028. Increased application of radioisotopes, increased public awareness, usage of SPECT/CT and PET/CT (hybrid imaging) imaging scanners, and technological advancements are driving the growth of the nuclear medicine market. Additionally,
Telemedicine Technologies Market Report is to growing at CAGR 20.20% by 2022, Size, Share, Forecast 2028, Aerotel Medical Systems Ltd, Alcatel-Lucent, At&T, Amd Telemedicine Inc, American Telecare Inc, Agfa Healthcare Nv
Telemedicine Technologies Market Report is to growing at CAGR 20.20% by 2022, Si …
Telemedicine Technologies Market Report is to growing at CAGR 20.20% by 2022. Telemedicine Technologies Market Report was 18.60% CAGR in 2018 and is expected to reach $XX Billion by the forecasted period 2022 to 2028. Telemedicine refers exclusively to the provision of health services and education at a distance, through the use of telecommunications technology. The use of telemedicine technologies to provide clinical services to patients. The technology is often

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug